If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPMorgan Indian Regulatory News (JII)

  • There is currently no data for JII

Appointment of Director

19 Dec 2023 16:02

RNS Number : 3572X
JPMorgan Indian Invest Trust PLC
19 December 2023
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

JPMORGAN INDIAN INVESTMENT TRUST PLC

 

 

APPOINTMENT OF DIRECTOR

 

 

Legal Entity Identifier: 5493006R74BNJSJKCB17

Information disclosed in accordance with Listing Rule 9.6.11(1)

 

 

The Board of JPMorgan Indian Investment Trust plc ('Company') is pleased to announce the appointment of Charlotta Ginman as a Non-Executive Director of the Company with effect from 1st August 2024.

Charlotta Ginman is a qualified Chartered Accountant and an experienced Non-Executive Director. She has held investment banking roles with UBS, Deutsche Bank and JP Morgan, moving onto senior finance roles with Nokia and Vertu.  After a successful executive career, she made a transition to Non-Executive Director roles with a broad range of international companies from technology to healthcare and financial services. Her previous appointments in the last five years include Motif Bio plc and Consort Medical plc.

Ms Ginman is currently Senior Independent Director (SID) and Audit Committee Chair of Keywords Studios plc, SID of Unicorn AIM VCT plc and Audit Committee Chair of Pacific Assets Trust plc (retiring in July 2024) and Gamma Communications plc. She is also a Non-Executive Director of Polar Capital Technology Trust plc (retiring in September 2024) and BOKU Inc.

Ms Ginman does not own any shares in the Company.

 

No further information is to be disclosed in respect of paragraphs 9.6.13(2) - (6) of the UKLA Listing Rules for Ms Ginman.

 

 

19th December 2023

 

 

For further information, please contact:

 

Divya Amin

 

JPMorgan Funds Limited, Secretary

Telephone 0800 20 40 20

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOANKCBKABDDDBD
Date   Source Headline
2nd Oct 202511:24 amRNSNet Asset Value(s)
2nd Oct 20259:46 amRNS-RInvestor Webinar
1st Oct 20253:23 pmRNSCompany Name Change
1st Oct 20252:04 pmRNSDividend Declaration & Company Name Change
1st Oct 20251:29 pmRNSClosed Period Notification
1st Oct 202512:04 pmRNSNet Asset Value(s)
1st Oct 20259:44 amRNSTotal Voting Rights
30th Sep 20254:43 pmRNSTransaction in Own Shares
30th Sep 202511:38 amRNSNet Asset Value(s)
29th Sep 20255:04 pmRNSTransaction in Own Shares
29th Sep 20251:25 pmRNSGearing Announcement
29th Sep 202511:13 amRNSNet Asset Value(s)
26th Sep 20255:16 pmRNSTransaction in Own Shares
26th Sep 202511:49 amRNSNet Asset Value(s)
25th Sep 20255:18 pmRNSTransaction in Own Shares
25th Sep 202511:09 amRNSNet Asset Value(s)
25th Sep 20257:00 amRNS-RInvestor Webinar
24th Sep 20254:57 pmRNSTransaction in Own Shares
24th Sep 202511:17 amRNSNet Asset Value(s)
23rd Sep 20255:12 pmRNSTransaction in Own Shares
23rd Sep 202510:29 amRNSNet Asset Value(s)
22nd Sep 20254:50 pmRNSTransaction in Own Shares
22nd Sep 202512:34 pmRNSEnhanced Dividend Distribution Policy
22nd Sep 202511:40 amRNSGearing announcement
22nd Sep 202511:27 amRNSNet Asset Value(s)
19th Sep 20255:22 pmRNSTransaction in Own Shares
19th Sep 202511:17 amRNSNet Asset Value(s)
18th Sep 20255:02 pmRNSTransaction in Own Shares
18th Sep 202511:25 amRNSNet Asset Value(s)
17th Sep 20255:15 pmRNSTransaction in Own Shares
17th Sep 202511:20 amRNSNet Asset Value(s)
16th Sep 202511:35 amRNSNet Asset Value(s)
15th Sep 202512:10 pmRNSGearing Announcement
15th Sep 202511:46 amRNSNet Asset Value(s)
12th Sep 20255:10 pmRNSTransaction in Own Shares
12th Sep 202510:39 amRNSNet Asset Value(s)
11th Sep 20255:03 pmRNSTransaction in Own Shares
11th Sep 202510:16 amRNSNet Asset Value(s)
10th Sep 20255:12 pmRNSTransaction in Own Shares
10th Sep 20254:32 pmRNSTen Largest Investments
10th Sep 202510:58 amRNSNet Asset Value(s)
9th Sep 20255:14 pmRNSTransaction in Own Shares
9th Sep 202511:21 amRNSNet Asset Value(s)
8th Sep 20255:22 pmRNSTransaction in Own Shares
8th Sep 202512:18 pmRNSGearing announcement
8th Sep 202511:43 amRNSNet Asset Value(s)
5th Sep 20254:54 pmRNSTransaction in Own Shares
5th Sep 202511:17 amRNSNet Asset Value(s)
4th Sep 20255:07 pmRNSTransaction in Own Shares
4th Sep 202511:05 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.